Table 2.

Comparison of ABCB1 polymorphisms with the characteristics

Characteristics	ABCB-CC	ABCB-CT	ABCB-TT	P
Number of patients	40	45	16	0.061
Recipient age in years (mean)	32.22	33.82	30.06	0.128
Donor age in years (mean)	48	50.1	48.13	0.28
Male: Female	33:7	40:5	4:12	0.212
Live donors	60%	80%	68.75%	0.741
Mean creatinine (mg/dL)	1.36	1.35	1.4	0.311
Tacrolimus dose (mg/day) (mean±SD)	4.5(±2.16)	4.23(±2.17)	3.83(±2.29)	0.575
Tacrolimus level (ng/mL) (mean±SD)	6.46(±3.15)	6.31(±2.15)	7.27(±3.59)	0.499
L/D ratio (ng/mL/mg/kg/day) (median: IQR)	74.45	87.75	116.71	0.26
Induction treatment	42.5%	31.11%	25%	0.10
Rejections	9 (22.5%)	9 (20%)	4 (25%)	0.65
CNI toxicity	3 (7.5%)	4 (8.95)	2 (12.5%)	0.32

ABCB1: ATP binding cassette subfamily B member1